vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Grand Canyon Education, Inc. (LOPE). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $308.1M, roughly 1.6× Grand Canyon Education, Inc.). Grand Canyon Education, Inc. runs the higher net margin — 28.1% vs -10.1%, a 38.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 5.3%). Grand Canyon Education, Inc. produced more free cash flow last quarter ($122.9M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 5.9%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Grand Canyon Education, Inc. (GCE) is an American for-profit corporation that provides services to universities, specializing in program development, online education, and operational support. Formerly affiliated with Grand Canyon University (GCU), a Christian university in Arizona, GCE became a separate publicly traded company in 2008.

CLOV vs LOPE — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.6× larger
CLOV
$487.7M
$308.1M
LOPE
Growing faster (revenue YoY)
CLOV
CLOV
+39.4% gap
CLOV
44.7%
5.3%
LOPE
Higher net margin
LOPE
LOPE
38.3% more per $
LOPE
28.1%
-10.1%
CLOV
More free cash flow
LOPE
LOPE
$191.8M more FCF
LOPE
$122.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
5.9%
LOPE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
LOPE
LOPE
Revenue
$487.7M
$308.1M
Net Profit
$-49.3M
$86.7M
Gross Margin
Operating Margin
-10.1%
35.1%
Net Margin
-10.1%
28.1%
Revenue YoY
44.7%
5.3%
Net Profit YoY
-123.2%
5.9%
EPS (diluted)
$3.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
LOPE
LOPE
Q4 25
$487.7M
$308.1M
Q3 25
$496.6M
$261.1M
Q2 25
$477.6M
$247.5M
Q1 25
$462.3M
$289.3M
Q4 24
$337.0M
$292.6M
Q3 24
$331.0M
$238.3M
Q2 24
$356.3M
$227.5M
Q1 24
$346.9M
$274.7M
Net Profit
CLOV
CLOV
LOPE
LOPE
Q4 25
$-49.3M
$86.7M
Q3 25
$-24.4M
$16.3M
Q2 25
$-10.6M
$41.5M
Q1 25
$-1.3M
$71.6M
Q4 24
$-22.1M
$81.9M
Q3 24
$-9.2M
$41.5M
Q2 24
$7.4M
$34.9M
Q1 24
$-19.2M
$68.0M
Gross Margin
CLOV
CLOV
LOPE
LOPE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
LOPE
LOPE
Q4 25
-10.1%
35.1%
Q3 25
-4.9%
6.9%
Q2 25
-2.2%
20.9%
Q1 25
-0.3%
30.4%
Q4 24
-6.4%
34.2%
Q3 24
-2.7%
20.2%
Q2 24
2.0%
18.8%
Q1 24
-6.5%
30.8%
Net Margin
CLOV
CLOV
LOPE
LOPE
Q4 25
-10.1%
28.1%
Q3 25
-4.9%
6.2%
Q2 25
-2.2%
16.8%
Q1 25
-0.3%
24.8%
Q4 24
-6.6%
28.0%
Q3 24
-2.8%
17.4%
Q2 24
2.1%
15.3%
Q1 24
-5.5%
24.8%
EPS (diluted)
CLOV
CLOV
LOPE
LOPE
Q4 25
$3.13
Q3 25
$0.58
Q2 25
$1.48
Q1 25
$2.52
Q4 24
$2.83
Q3 24
$1.42
Q2 24
$1.19
Q1 24
$2.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
LOPE
LOPE
Cash + ST InvestmentsLiquidity on hand
$78.3M
$111.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$746.9M
Total Assets
$541.0M
$992.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
LOPE
LOPE
Q4 25
$78.3M
$111.8M
Q3 25
$97.3M
Q2 25
$192.3M
Q1 25
$144.5M
Q4 24
$194.5M
$324.6M
Q3 24
$288.0M
$263.6M
Q2 24
$254.8M
$241.3M
Q1 24
$208.3M
$196.2M
Stockholders' Equity
CLOV
CLOV
LOPE
LOPE
Q4 25
$308.7M
$746.9M
Q3 25
$340.9M
$758.0M
Q2 25
$344.2M
$778.0M
Q1 25
$336.1M
$780.7M
Q4 24
$341.1M
$783.9M
Q3 24
$342.2M
$764.1M
Q2 24
$324.9M
$759.2M
Q1 24
$292.5M
$759.4M
Total Assets
CLOV
CLOV
LOPE
LOPE
Q4 25
$541.0M
$992.3M
Q3 25
$559.7M
$1.0B
Q2 25
$575.0M
$1.0B
Q1 25
$583.7M
$1.0B
Q4 24
$580.7M
$1.0B
Q3 24
$653.0M
$992.9M
Q2 24
$674.2M
$992.7M
Q1 24
$671.8M
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
LOPE
LOPE
Operating Cash FlowLast quarter
$-66.9M
$130.5M
Free Cash FlowOCF − Capex
$-69.0M
$122.9M
FCF MarginFCF / Revenue
-14.1%
39.9%
Capex IntensityCapex / Revenue
0.4%
2.5%
Cash ConversionOCF / Net Profit
1.50×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$238.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
LOPE
LOPE
Q4 25
$-66.9M
$130.5M
Q3 25
$12.1M
$-48.6M
Q2 25
$5.4M
$124.0M
Q1 25
$-16.3M
$67.6M
Q4 24
$34.8M
$135.8M
Q3 24
$50.0M
$-29.4M
Q2 24
$44.8M
$98.6M
Q1 24
$25.9M
$85.0M
Free Cash Flow
CLOV
CLOV
LOPE
LOPE
Q4 25
$-69.0M
$122.9M
Q3 25
$11.4M
$-58.3M
Q2 25
$4.8M
$115.4M
Q1 25
$-16.5M
$58.7M
Q4 24
$33.3M
$126.1M
Q3 24
$49.6M
$-39.0M
Q2 24
$44.4M
$89.6M
Q1 24
$25.5M
$76.0M
FCF Margin
CLOV
CLOV
LOPE
LOPE
Q4 25
-14.1%
39.9%
Q3 25
2.3%
-22.3%
Q2 25
1.0%
46.6%
Q1 25
-3.6%
20.3%
Q4 24
9.9%
43.1%
Q3 24
15.0%
-16.3%
Q2 24
12.5%
39.4%
Q1 24
7.3%
27.7%
Capex Intensity
CLOV
CLOV
LOPE
LOPE
Q4 25
0.4%
2.5%
Q3 25
0.1%
3.7%
Q2 25
0.1%
3.5%
Q1 25
0.0%
3.1%
Q4 24
0.5%
3.3%
Q3 24
0.1%
4.0%
Q2 24
0.1%
3.9%
Q1 24
0.1%
3.3%
Cash Conversion
CLOV
CLOV
LOPE
LOPE
Q4 25
1.50×
Q3 25
-2.99×
Q2 25
2.98×
Q1 25
0.94×
Q4 24
1.66×
Q3 24
-0.71×
Q2 24
6.04×
2.83×
Q1 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons